Angelo De Marzo

3.4k total citations
23 papers, 1.7k citations indexed

About

Angelo De Marzo is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Angelo De Marzo has authored 23 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 10 papers in Pulmonary and Respiratory Medicine and 7 papers in Oncology. Recurrent topics in Angelo De Marzo's work include Prostate Cancer Treatment and Research (8 papers), Epigenetics and DNA Methylation (3 papers) and Cancer-related Molecular Pathways (3 papers). Angelo De Marzo is often cited by papers focused on Prostate Cancer Treatment and Research (8 papers), Epigenetics and DNA Methylation (3 papers) and Cancer-related Molecular Pathways (3 papers). Angelo De Marzo collaborates with scholars based in United States, China and Türkiye. Angelo De Marzo's co-authors include Pedram Argani, George J. Netto, Christine A. Iacobuzio–Donahue, Charles J. Yeo, Anirban Maitra, Ralph H. Hruban, John L. Cameron, Volkan Adsay, Tullia C. Bruno and Timothy Harris and has published in prestigious journals such as Journal of Clinical Investigation, PLoS ONE and Cancer.

In The Last Decade

Angelo De Marzo

23 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Angelo De Marzo United States 15 867 839 399 371 332 23 1.7k
Hiroki Hashida Japan 16 1.0k 1.2× 768 0.9× 404 1.0× 359 1.0× 181 0.5× 58 1.8k
Wiam Bshara United States 25 746 0.9× 811 1.0× 314 0.8× 402 1.1× 328 1.0× 73 1.7k
David Balli United States 16 826 1.0× 764 0.9× 264 0.7× 360 1.0× 464 1.4× 31 1.6k
Leticia Oliveira‐Ferrer Germany 25 712 0.8× 1.4k 1.6× 458 1.1× 645 1.7× 362 1.1× 76 2.3k
Élodie Vauléon France 24 596 0.7× 522 0.6× 302 0.8× 302 0.8× 414 1.2× 60 1.8k
Asumi Yokota Japan 25 519 0.6× 817 1.0× 323 0.8× 273 0.7× 171 0.5× 61 1.8k
Gerwin Heller Austria 25 583 0.7× 1.2k 1.5× 333 0.8× 485 1.3× 308 0.9× 77 2.0k
Zhong‐Sheng Zhao China 25 513 0.6× 896 1.1× 163 0.4× 524 1.4× 305 0.9× 69 1.5k
Ernst J.A. Steller Netherlands 15 741 0.9× 717 0.9× 241 0.6× 424 1.1× 151 0.5× 20 1.5k
Anita Wolfer Switzerland 13 690 0.8× 1.3k 1.6× 454 1.1× 352 0.9× 127 0.4× 32 2.2k

Countries citing papers authored by Angelo De Marzo

Since Specialization
Citations

This map shows the geographic impact of Angelo De Marzo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Angelo De Marzo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Angelo De Marzo more than expected).

Fields of papers citing papers by Angelo De Marzo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Angelo De Marzo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Angelo De Marzo. The network helps show where Angelo De Marzo may publish in the future.

Co-authorship network of co-authors of Angelo De Marzo

This figure shows the co-authorship network connecting the top 25 collaborators of Angelo De Marzo. A scholar is included among the top collaborators of Angelo De Marzo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Angelo De Marzo. Angelo De Marzo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shenderov, Eugene, Angelo De Marzo, Tamara L. Lotan, et al.. (2021). 627P Phase II neoadjuvant trial of the anti–B7-H3 antibody, enoblituzumab, in men with localized prostate cancer: Safety, efficacy and immune correlates. Annals of Oncology. 32. S662–S663. 2 indexed citations
2.
Schweizer, Michael T., Hao Wang, Trinity J. Bivalacqua, et al.. (2019). A Phase I Study to Assess the Safety and Cancer-Homing Ability of Allogeneic Bone Marrow-Derived Mesenchymal Stem Cells in Men with Localized Prostate Cancer. Stem Cells Translational Medicine. 8(5). 441–449. 58 indexed citations
3.
Amend, Sarah R., et al.. (2019). Polyploid giant cancer cells: Unrecognized actuators of tumorigenesis, metastasis, and resistance. The Prostate. 79(13). 1489–1497. 127 indexed citations
4.
Nash, Sarah H., Jeannette M. Schenk, Alan R. Kristal, et al.. (2015). Association between Serum Phospholipid Fatty Acids and Intraprostatic Inflammation in the Placebo Arm of the Prostate Cancer Prevention Trial. Cancer Prevention Research. 8(7). 590–596. 8 indexed citations
5.
Liang, Jiaqian, Yirong Li, Garrett Daniels, et al.. (2015). LEF1 Targeting EMT in Prostate Cancer Invasion Is Regulated by miR-34a. Molecular Cancer Research. 13(4). 681–688. 78 indexed citations
6.
Ahearn, Thomas U., Andreas Pettersson, Ericka M. Ebot, et al.. (2015). MP6-15 PTEN LOSS AND ERG EXPRESSION IN PROSTATE CANCER SURVIVAL. The Journal of Urology. 193(4S). 1 indexed citations
7.
Mendonca, Janet, Anup Sharma, Hans J. Hammers, et al.. (2014). Selective inhibitors of nuclear export (SINE) as novel therapeutics for prostate cancer. Oncotarget. 5(15). 6102–6112. 53 indexed citations
8.
Chung, Charles C., Ann W. Hsing, Edward D. Yeboah, et al.. (2014). A comprehensive resequence‐analysis of 250 kb region of 8q24.21 in men of African ancestry. The Prostate. 74(6). 579–589. 20 indexed citations
9.
Cimino‐Mathews, Ashley, Jessica Hicks, Rajni Sharma, et al.. (2013). A subset of malignant phyllodes tumors harbors alterations in the Rb/p16 pathway. Human Pathology. 44(11). 2494–2500. 22 indexed citations
10.
Haffner, Michael C., Susmita Ghosh, Tamara L. Lotan, et al.. (2013). Tight correlation of 5-hydroxymethylcytosine and Polycomb marks in health and disease. Cell Cycle. 12(12). 1835–1841. 22 indexed citations
11.
Christudass, Christhunesa S., et al.. (2012). Abstract 3640: Overexpression of five novel biomarkers in human prostate tissues and cell lines. Cancer Research. 72(8_Supplement). 3640–3640. 1 indexed citations
12.
Ji, Hongkai, George Y. Wu, Xiangcan Zhan, et al.. (2011). Cell-Type Independent MYC Target Genes Reveal a Primordial Signature Involved in Biomass Accumulation. PLoS ONE. 6(10). e26057–e26057. 133 indexed citations
13.
Hansel, Donna E., Mohammed S. Orloff, Jessica Hicks, et al.. (2010). Mammalian Target of Rapamycin (mTOR) Regulates Cellular Proliferation and Tumor Growth in Urothelial Carcinoma. American Journal Of Pathology. 176(6). 3062–3072. 67 indexed citations
14.
Fujita, Kazutoshi, Christian P. Pavlovich, George J. Netto, et al.. (2009). Specific detection of prostate cancer cells in urine by multiplex immunofluorescence cytology. Human Pathology. 40(7). 924–933. 40 indexed citations
15.
Geller, James I., Pedram Argani, Adebowale Adeniran, et al.. (2008). Translocation renal cell carcinoma. Cancer. 112(7). 1607–1616. 129 indexed citations
16.
Cao, Dengfeng, Kornélia Polyák, Marc K. Halushka, et al.. (2008). Serial analysis of gene expression of lobular carcinoma in situ identifies down regulation of claudin 4 and overexpression of matrix metalloproteinase 9. Breast Cancer Research. 10(5). R91–R91. 24 indexed citations
17.
Inoue, Hitoshi, Elizabeth A. Platz, Yasutomo Nakai, et al.. (2008). Mapping of DNA methylation status of GSTP1 CpG island in human prostate tissue. 68. 4281–4281. 1 indexed citations
18.
Grosso, Joseph F., Timothy Harris, Charles H. Maris, et al.. (2007). LAG-3 regulates CD8+ T cell accumulation and effector function in murine self- and tumor-tolerance systems. Journal of Clinical Investigation. 117(11). 3383–3392. 433 indexed citations
19.
Maitra, Anirban, Volkan Adsay, Pedram Argani, et al.. (2003). Multicomponent Analysis of the Pancreatic Adenocarcinoma Progression Model Using a Pancreatic Intraepithelial Neoplasia Tissue Microarray. Modern Pathology. 16(9). 902–912. 298 indexed citations
20.
Yang, Guang, Gustavo Ayala, Angelo De Marzo, et al.. (2002). Elevated Skp2 protein expression in human prostate cancer: association with loss of the cyclin-dependent kinase inhibitor p27 and PTEN and with reduced recurrence-free survival.. PubMed. 8(11). 3419–26. 176 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hiroki Hashida Breakdown of academic impact, for papers by Wiam Bshara Breakdown of academic impact, for papers by David Balli Breakdown of academic impact, for papers by Leticia Oliveira‐Ferrer Breakdown of academic impact, for papers by Élodie Vauléon Breakdown of academic impact, for papers by Asumi Yokota Breakdown of academic impact, for papers by Gerwin Heller Breakdown of academic impact, for papers by Zhong‐Sheng Zhao Breakdown of academic impact, for papers by Ernst J.A. Steller Breakdown of academic impact, for papers by Anita Wolfer
Rankless by CCL
2026